FDA official logo
GSRS logo
PFDA official logo

RITUXIMAB

  • UNII: 4F4X42SYQ6
  • Preferred Substance Name: RITUXIMAB

  • 174722-31-7
  • ABP798
  • ABP-798
  • BI695500
  • BI-695500
  • BI-695500 [WHO-DD]
  • BLITZIMA
  • CT-P10
  • GP2013
  • IDEC-102
  • IDEC-C2B8
  • IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
  • MAB CHIMERIC (IGG1) ANTI P11836 (CD20_HUMAN) (IDECC2B8)
  • MABTHERA
  • MK-8808
  • PF-05280586
  • RG-105
  • RIABNI
  • RITEMVIA
  • RITUXAN
  • RITUXAN HYCELA COMPONENT RITUXIMAB
  • RITUXIMAB (GENETICAL RECOMBINATION)
  • RITUXIMAB [EMA EPAR]
  • RITUXIMAB [HSDB]
  • RITUXIMAB [INN]
  • RITUXIMAB [JAN]
  • RITUXIMAB [MART.]
  • RITUXIMAB [MI]
  • RITUXIMAB [PURPLE BOOK CDER]
  • RITUXIMAB [USAN]
  • RITUXIMAB [VANDF]
  • RITUXIMAB [WHO-DD]
  • RITUXIMAB BIOSIMILAR - CELLTRION
  • RITUXIMAB BIOSIMILAR -MERCK
  • RITUXIMAB BIOSIMILAR-ALLERGAN/AMGEN
  • RITUXIMAB COMPONENT OF RITUXAN HYCELA
  • RITUXIMAB-ABBS
  • RITUXIMAB-ABBS [PURPLE BOOK, CDER]
  • RITUXIMAB-ARRX
  • RITUXIMAB-BOEHRINGER INGELHEIM
  • RITUXIMAB-CT-P10
  • RITUXIMAB-PFIZER
  • RITUXIMAB-PVVR
  • RUXIENCE
  • TRUXIMA
  • TUXELLA
  • USP MAB 001, MONOCLONAL IGG1 [USP-RS]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.